Xencor Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 19, 2020 / 05:00PM GMT
Erin Primdahl -

Welcome to the Jefferies Virtual Health Care Conference. My name is Erin Primdahl, and it is my great pleasure to introduce Bassil Dahiyat, President and CEO of Xencor. If time allows, we will take a few questions from the audience at the end of the session. (Operator Instructions) I will now pass it over to Bassil.

Bassil I. Dahiyat - Xencor, Inc. - Co-Founder, CEO, President & Director

Thanks, Erin. It's a pleasure to be attending the Jefferies Virtual Conference this year. I'm looking forward to telling everybody a little bit about Xencor. This is our forward-looking statement slide. So Xencor is a company that does antibody engineering. We specifically focus on trying to engineer the structure and immune functions of antibodies to make them better drugs. We do this by focusing on engineering the bottom half of antibodies that are colored here in blue, which is called the Fc domain. We've engineered a whole host of variant Fc domains where we introduced specific amino acid mutations and these Fc domains are called our XmAb Fc domains. And these

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot